U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced ...
Fierce Pharma

Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca

The increasingly more popular combination of Padcev and Keytruda has expanded its bladder cancer territory once again. | The ...
MedPage Today

FDA Expands Approval of Chemo-Free Bladder Cancer Combo in Curative Setting

The FDA approved pembrolizumab (Keytruda) or pembrolizumab and berahyaluronidase alfa (Keytruda Qlex) in combination with ...

Pfizer, Astellas expand PADCEV-Keytruda label with FDA nod in bladder cancer

On Friday, the U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s PFE and Astellas Pharma Inc.’s ALPMF ALPMY ...

Merck, Pfizer, Astellas Bladder Cancer Treatment Approved by FDA

The Food and Drug Administration approved a combination treatment by Merck & Co., Pfizer, and Astellas Pharma for a hard-to-treat form of bladder cancer. The agency greenlit Merck's Keytruda and its ...
Healio

Pembrolizumab regimens snag FDA nod for muscle-invasive bladder cancer

The FDA has approved two immunotherapy combination therapies for adults with muscle-invasive bladder cancer. Pembrolizumab ...

UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer

FDA clearance enables initiation of a planned Phase 1 clinical study evaluating local intravesical administration of UGN-501, with patient ...
Cure Today

Whole Pelvis Radiation in Muscle-Invasive Bladder Cancer May Improve Survival

Whole pelvis radiation improves cancer-specific and overall survival in muscle-invasive bladder cancer compared to bladder-only radiation. Median cancer-specific survival was 84 months for whole ...
Cure Today

What Are Non-Muscle Invasive Bladder Cancer and its Treatment Options?

NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...